| Ticker Symbol: | ONXX |
|---|---|
| Exchange: | NASD |
| Contact Info: | 2100 Powell Street Emeryville CA 94608 510 597-6500 |
| CEO/President: | Hollings C. Renton |
| Industry: | Medical - Drugs / Standard Industry Code: 2836 |
| Description: | Onyx Pharmaceuticals, Inc is developing innovative products for the treatment of cancer. |
| Shares Outstanding: | 56,130 (000) | Market Value: | 1,577,390 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 93.35% | Number of Inst.Shareholders: | 7.00% |
| Last Quarter Sales: | 39.92 ($Mil.) | Last Quarter Net Income: | 12.24 ($Mil.) |
| Last Quarter EPS: | 0.21 | P/E Ratio: | 80 |
| Most Recent Earnings: | 0.21 on 11/06/08 | Earnings Per Share: | 0.35 |
| Most Recent Split: | Annual Dividend Rate: | 0 | |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |

| PFIZER INC | -28.80 | 16.07 | |
| JOHNSON AND JOH | -15.00 | 58.27 | |
| BRISTOL MYERS S | -22.20 | 20.57 | |
| SCHERING PLOUGH | -39.90 | 16.47 | |
| MERCK CO INC | -54.90 | 26.31 |
